Acromegaly Clinical Trials

A listing of Acromegaly medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Advanced Research
Peoria Arizona 85381

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

California

UCLA School of Medicine
Los Angeles California 90095

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Coastal Metabolic Research Center University Medical Center, Dept. of Endocrinology
Ventura California 93003

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

La Jolla California 92037

A Phase 4 clinical study for patients using Pasireotide

Los Angeles California 90048

A Phase 4 clinical study for patients using Pasireotide

Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating Sandostatin LAR for the treatment of Acromegaly

Multiple Locations California

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Stanford California 94304

A Phase 4 clinical study for patients using Pasireotide

Torrance California 90502

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Ventura California 93003

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Florida

Jacksonville Florida 32223

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Illinois

Chicago Illinois 60612

A clinical research study of octreotide capsules and Matching placebo for the treatment of Acromegaly

Maryland

Johns Hopkins University School of Medicine Division of Endocrinology, Diabetes & Metabolism
Baltimore Maryland 21287

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Michigan

University of Michigan Medical Center Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Ann Arbor Michigan 48109

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Ann Arbor Michigan 48109-0944

A Phase 4 clinical study for patients using Pasireotide

Missouri

St. Louis Missouri 63110

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Montana

Great Falls Montana 59405

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

New Jersey

New Brunswick New Jersey 08901

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

New Mexico

University of New Mexico HSC
Albuquerque New Mexico 87131

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

New York

Icahn School of Medicine at Mount Sinai
New York New York 10029

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

New York New York 10029

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

New York New York 10032

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

New York New York 10075

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

New York New York 10032

A clinical trial to evaluate treatments using Pegvisomant for patients with Acromegaly or Osteoporosis Risk

New York New York 10029

A Phase 4 clinical study for patients using Pasireotide

New York New York 10065

A Phase 4 clinical study for patients using Pasireotide

Ohio

Cleveland Clinic Endocrinology
Cleveland Ohio 44195

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

CarePoint East
Columbus Ohio 43203

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Oregon

Oregon Health & Science University
Portland Oregon

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Pennsylvania

University of Pennslyvania Smilow Center for Translational Research
Philadelphia Pennsylvania 19104-5160

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Pittsburgh Pennsylvania 15212

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Pittsburgh Pennsylvania 15212

A clinical research study of octreotide capsules and Matching placebo for the treatment of Acromegaly

Rhode Island

Rhode Island Hospital, Hallett Center for Diabetes and Endocrinology
East Providence Rhode Island 02914

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Tennessee

Nashville Tennessee 37212-8210

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Texas

Houston Texas 77030

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Virginia

Chesapeake Virginia 23321

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Chesapeake Virginia 23321

A Phase 4 clinical study for patients using Pasireotide

Washington

Swedish Neuroscience Research
Seattle Washington 98122

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Seattle Washington 98122-4379

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Seattle Washington 98104

A Phase 4 clinical study for patients using Pasireotide

Argentina

Caba Buenos Aires C1405BCH

A Phase 4 clinical study for patients using Pasireotide

Austria

Graz A-8036

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Wien A-1090

Patients are needed to participate in a clinical research study of Octreotide capsules, Injectable Somatostatin Analogs (octreotide or lanreotide) and Cabergoline to evaluate Acromegaly

Belgium

Universitair Ziekenhuis
Brussels International 1090

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

UZLeuven Dienst endocrinologie
Leuven International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Brugge 8310

A Phase 4 clinical study for patients using Pasireotide

Brussels 1200

A Phase 4 clinical study for patients using Pasireotide

Brussels 1090

A Phase 4 clinical study for patients using Pasireotide

Edegem 2650

A Phase 4 clinical study for patients using Pasireotide